Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1
Abstract Background Skeletal muscle atrophy is a common condition without a pharmacologic therapy. AGGF1 encodes an angiogenic factor that regulates cell differentiation, proliferation, migration, apoptosis, autophagy and endoplasmic reticulum stress, promotes vasculogenesis and angiogenesis and suc...
Saved in:
Main Authors: | Zuhan He (Author), Qixue Song (Author), Yubing Yu (Author), Feng Liu (Author), Jinyan Zhao (Author), Waikeong Un (Author), Xingwen Da (Author), Chengqi Xu (Author), Yufeng Yao (Author), Qing K. Wang (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulation of skeletal muscle atrophy
by: Shigetada Teshima-Kondo, et al.
Published: (2013) -
Inflammation: Roles in Skeletal Muscle Atrophy
by: Yanan Ji, et al.
Published: (2022) -
Potential Therapeutic Strategies for Skeletal Muscle Atrophy
by: Li Huang, et al.
Published: (2022) -
Handelin alleviates cachexia‐ and aging‐induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation
by: Hui‐Jie Zhang, et al.
Published: (2024) -
Role of Ca2+ signaling in skeletal muscle hypertrophy and atrophy
by: Naoki Ito, et al.
Published: (2015)